Single peptide

KPV

A very short peptide studied in cells and animals for inflammation-related effects.

Open calculator → View research listing ↗External listing at JD BioWorks

Whole vial: 10 mg Vial math ↓

01 / Overview

Why people look it up

KPV is discussed mainly because researchers have looked at its effects on gut inflammation and immune signals in cells and animals.

  • Gut inflammationANIMAL / PRECLINICAL EVIDENCE

    Mouse colitis experiments found inflammation-related changes. Read source ↗

  • Cellular inflammatory signalingMECHANISTIC / LAB EVIDENCE

    Cell experiments explored how KPV interacts with inflammation pathways. Read source ↗

  • Human IBD treatmentINSUFFICIENT EVIDENCE

    The cited mouse and cell studies did not test clinical outcomes in people. Read source ↗

The labels show the evidence for each claim. Open a row for its source.

02 / Amounts & schedules

Dosage at a glance

Published chart examples

Dosage source summary

Lower example
200 mcg
Middle example
300 / 400 mcg
Higher example
500 mcg
How often
Once daily in the published example
Time on / time off
The chart does not establish an agreed break schedule.
Route
Subcutaneous in that chart

The middle cell retains both intermediate rows in the source chart; it is not a calculated midpoint.

These source amounts do not establish a safe human dose for a research vial.

Sources & individual reports
Source of the amount boxes
  • PeptideDosages published chart; reviewed October 18, 2026

The middle cell retains both intermediate rows in the source chart; it is not a calculated midpoint. Source check: 2026-10-18.

Source coverage: 1 reviewed public account. Not a community consensus.

Report 1 ↗First-person account

Amount reported
500 mcg KPV each time
How often reported
daily
Reported duration / cycle
July 28 to September 28, with stated plan to continue
Route (how it was taken)
subcutaneous, as stated by poster

What the account says: Poster also used thymosin alpha-1 and prescribed hydroxychloroquine for rheumatoid arthritis. Biomarker changes cannot be assigned to KPV.

Product match & source details

Product match: The product was not analytically verified as this vial.

r/KPVPeptide firsthand post · Posted: date not independently verified · Reviewed: 2026-10-03.

How much agreement is there? The checked account is a single example; route and formulation vary widely in public discussion.

Public sources last reviewed: 2026-10-03. Product identity and reported results were not independently verified. Source method →

03 / Go deeper

Evidence, sources & vial math

What the research actually showsHuman studies, evidence limits and mechanisms
Published evidence, separate from public reports

What has actually been studied?

How we read studies ↗

Mouse colitis and cell experiments suggest anti-inflammatory mechanisms. They do not establish treatment of human inflammatory bowel disease or other inflammatory conditions.

Evidence limits: Controlled human outcomes, human dosing, and long-term safety for this research vial are not established by the cited preclinical work.

Product status: Research-vial listings are not FDA-approved medicines. Approved-use labels on this page refer only to the named finished prescription product.

Human research

The reviewed KPV evidence is from cultured cells and mice; no directly administered human KPV treatment study was extracted. A human study of K(D)PT uses a different D-proline peptide and cannot be counted as a KPV trial.

Reviewed cited studies and the linked product or regulator documentation; absence of an extracted trial is not proof that no study exists.

Study and prescription-product amounts describe those sources. They do not select an amount for an online research vial.

How researchers think it might work

In cell and mouse experiments, KPV entered certain cells through a small-peptide transporter and reduced measured inflammation signals. That has not been shown to treat people.

Show scientific explanation

A primary study reported PepT1-dependent uptake of KPV, reduced NF-kappaB and MAPK signaling in cultured cells, and reduced colitis measures in two mouse models. It did not administer KPV to human patients. Read supporting source ↗

Vial & syringe mathTurn the vial total and liquid volume into concentration and syringe units
Make sense of the vial

Vial & syringe math

Change the vial total and final liquid volume to see what each U-100 syringe mark represents.

The starting 1 mL is a math example. Enter your final mixed volume to update the numbers.

Concentration (mg per mL)—
In 1 U-100 syringe unit—
In 10 U-100 syringe units—

100 U-100 syringe units = 1 mL. These results assume the labeled amount is evenly mixed through the final liquid volume.

Continue in the calculator →
About this listingResearch-use-only status, seller names and additional background

A research material is not intended for human use. Its name or lab report does not establish suitability for a person. What research use only means →

Compiled by PeptideWhy · Scientific sources last checked 2026-10-03 · Editorial policy · Corrections